Infection

DefinitionNLM MeSH D007239

Invasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases.

Source: U.S. National Library of Medicine — MeSH (Infections)

Drugs reporting Infection (129)

Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.

1. 1Dyclonine7065%
2. 2Benzalkonium12024%
3. 3Fosamprenavir2519%
4. 4Desogestrel74819%
5. 5Leniolisib12116%
6. 6Acellular Tissue Engineered Vessel113%
7. 7Crovalimab911%
8. 8Darifenacin8710%
9. 9Procainamide177.1%
10. 10Cefaclor1056.9%
11. 11Obecabtagene Autoleucel26.7%
12. 12Abatacept8,3886.2%
13. 13Proteus Mirabilis26.1%
14. 14Immunoglobulin G1,1585.9%
15. 15Quizartinib325.8%
16. 16Certolizumab Pegol6,5995.8%
17. 17Proteus Vulgaris25.7%
18. 18Anakinra8935.5%
19. 19Potassium Phosphate1685.4%
20. 20Teclistamab1025.2%
21. 21Trilaciclib125.1%
22. 22Rituximab10,9635.1%
23. 23Aprepitant9075.0%
24. 24Meperidine4545.0%
25. 25Palifermin194.9%
26. 26Dornase Alfa9414.9%
27. 27Thiotepa4184.5%
28. 28Glofitamab914.4%
29. 29Fosaprepitant5984.4%
30. 30Idarubicin484.4%
31. 31Methoxsalen334.4%
32. 32Lumacaftor3694.3%
33. 33Cefiderocol134.3%
34. 34Elranatamab364.1%
35. 35Decitabine2014.1%
36. 36Gilteritinib1504.0%
37. 37Pamidronate1334.0%
38. 38Metyrosine33.9%
39. 39Orphenadrine293.9%
40. 40Ivacaftor1,3063.9%
41. 41Talquetamab713.9%
42. 42Tezacaftor6883.9%
43. 43Dicloxacillin73.8%
44. 44Nipocalimab63.8%
45. 45Carmustine1743.8%
46. 46Ifosfamide7953.8%
47. 47Azacitidine1,0843.8%
48. 48Obinutuzumab5933.8%
49. 49Tavaborole23.6%
50. 50Fludarabine1,3633.6%
51. 51Aztreonam2483.5%
52. 52Zafirlukast303.5%
53. 53Busulfan6213.4%
54. 54Doxycycline2,3213.4%
55. 55Tobramycin9123.3%
56. 56Venetoclax1,9263.2%
57. 57Mitoxantrone1973.2%
58. 58Inotuzumab Ozogamicin913.2%
59. 59Chlorambucil1233.2%
60. 60Plerixafor453.1%
61. 61Methotrexate15,0263.1%
62. 62Cytarabine1,8663.1%
63. 63Sulfamethoxazole2,5383.1%
64. 64Trimethoprim2,8713.1%
65. 65Melphalan7563.1%
66. 66Amylase1953.0%
67. 67Protease1953.0%
68. 68Cedazuridine233.0%
69. 69Calcium Chloride1,4692.9%
70. 70Birch Triterpenes52.9%
71. 71Bendamustine7742.9%
72. 72Inebilizumab152.9%
73. 73Lipase1982.9%
74. 74Mycophenolate3,7252.8%
75. 75Mycophenolate Mofetil3,7252.8%
76. 76Valrubicin52.8%
77. 77Magnesium Chloride1,4032.8%
78. 78Interferon Gamma-1b392.8%
79. 79Satralizumab442.8%
80. 80Floxuridine42.8%
81. 81Elexacaftor3372.8%
82. 82Daunorubicin1012.8%
83. 83Polatuzumab Vedotin2512.8%
84. 84Etoposide2,0092.8%
85. 85Temozolomide5652.7%
86. 86Cyclophosphamide4,5442.6%
87. 87Filgrastim1,0862.6%
88. 88Dexrazoxane232.6%
89. 89Icodextrin7872.6%
90. 90Loncastuximab Tesirine92.6%
91. 91Rezafungin22.6%
92. 92Tafasitamab222.5%
93. 93Deferoxamine532.5%
94. 94Isatuximab1312.5%
95. 95Mesna2012.4%
96. 96Luliconazole42.4%
97. 97Carfilzomib6532.4%
98. 98Micafungin1942.3%
99. 99Doxorubicin2,1842.3%
100. 100Sirolimus2982.3%
101. 101Potassium Bitartrate42.3%
102. 102Ivosidenib442.3%
103. 103Oxacillin252.3%
104. 104Sodium Chloride6,0182.3%
105. 105Thalidomide7802.1%
106. 106Glasdegib102.1%
107. 107Avacopan1202.1%
108. 108Lactate1,5402.1%
109. 109Idelalisib1452.1%
110. 110Daratumumab8342.0%
111. 111Defibrotide712.0%
112. 112Ciltacabtagene Autoleucel991.9%
113. 113Mogamulizumab241.9%
114. 114Prednisolone3,5411.9%
115. 115Posaconazole2921.9%
116. 116Fibrinogen61.9%
117. 117Epcoritamab211.8%
118. 118Sebetralstat31.8%
119. 119Isavuconazonium601.8%
120. 120Lumasiran61.7%
121. 121Elapegademase51.7%
122. 122Elotuzumab841.6%
123. 123Ponesimod51.6%
124. 124Paricalcitol2071.5%
125. 125Baricitinib1371.5%
126. 126Ritlecitinib251.4%
127. 127Blinatumomab257—
128. 128Boric Acid110—
129. 129Brexucabtagene Autoleucel47—

Related reactions

Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.

• Sepsis59 shared · 0.21
• Febrile Neutropenia48 shared · 0.20
• Neutropenia58 shared · 0.20
• Thrombocytopenia49 shared · 0.16
• Pancytopenia26 shared · 0.13
• Disease Progression41 shared · 0.13
• Platelet Count Decreased32 shared · 0.13
• Acute Myeloid Leukaemia16 shared · 0.12
• Pneumonia93 shared · 0.11
• White Blood Cell Count Decreased21 shared · 0.11

Literature

Recent PubMed references pinned to Infections as a MeSH major topic. About the reaction term itself — not about any specific drug.

• CircRNA based bi-antigen vaccines against mpox virus induce potent and durable cross-protection in mice.
  Molecular biomedicine · 2026 · Zhou J, Wang C, Wu Y, et al.
  PMID 42207442DOI 10.1186/s43556-026-00474-9
• Selenium-enriched probiotics improve growth performance in PCV2-infected weaned piglets by regulating antioxidant systems and immune responses.
  Veterinary research communications · 2026 · Wang C, Xu W, Chen C, et al.
  PMID 42207408DOI 10.1007/s11259-026-11293-2
• Circulating Tumor High Risk HPV DNA as the HPV-Specific Test in Oropharyngeal Squamous Cell Carcinoma Patients.
  Head and neck pathology · 2026 · Hidalgo CM, Yin LX, Bogan AW, et al.
  PMID 42207402DOI 10.1007/s12105-026-01911-5
• Seroprevalence of Orthoflaviviruses in horses in 3 different Algerian climatic zones between 2021 and 2023.
  Tropical animal health and production · 2026 · Boukabache H, Gonzalez G, Helle T, et al.
  PMID 42207390DOI 10.1007/s11250-026-05070-1
• Cyclomodulins and supplementary virulence genes as determinants of clinical severity and antimicrobial resistance in uropathogenic Escherichia coli and Klebsiella pneumoniae.
  World journal of microbiology & biotechnology · 2026 · Monroy-Higuera J, Angulo-Zamudio UA, Leon-Sicairos N, et al.
  PMID 42207375DOI 10.1007/s11274-026-05045-2
• Galangin modulates the NRF2/PPAR-Γ pathway, attenuating sepsis-induced tissue damage in the lungs.
  Molecular biology reports · 2026 · Aydin P, Toktay E, Cadirci E, et al.
  PMID 42207369DOI 10.1007/s11033-026-11931-7